4-56467653-C-CG
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2
The NM_006947.4(SRP72):c.25dupG(p.Val9GlyfsTer9) variant causes a frameshift change. The variant allele was found at a frequency of 0.0000374 in 1,550,684 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. V9null) has been classified as Uncertain significance.
Frequency
Consequence
NM_006947.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant aplasia and myelodysplasiaInheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
- acute myeloid leukemiaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151404Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000461 AC: 9AN: 195388 AF XY: 0.0000276 show subpopulations
GnomAD4 exome AF: 0.0000393 AC: 55AN: 1399280Hom.: 0 Cov.: 30 AF XY: 0.0000360 AC XY: 25AN XY: 694660 show subpopulations
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151404Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 73924 show subpopulations
ClinVar
Submissions by phenotype
not provided Uncertain:2
This sequence change creates a premature translational stop signal (p.Val9Glyfs*9) in the SRP72 gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in SRP72 cause disease. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with SRP72-related conditions. ClinVar contains an entry for this variant (Variation ID: 1723735). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene or region of a gene for which loss of function is not an established mechanism of disease; Has not been previously published as pathogenic or benign to our knowledge -
SRP72-related disorder Uncertain:1
The SRP72 c.25dupG variant is predicted to result in a frameshift and premature protein termination (p.Val9Glyfs*9). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.012% of alleles in individuals of South Asian descent in gnomAD. Loss of function has not been conclusively established as a mechanism for SRP72-related disorders. Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Autosomal dominant aplasia and myelodysplasia Uncertain:1
The SRP72 c.25dup (p.Val9GlyfsTer9) change causes a frameshift of the protein coding sequence and the creation of a premature stop codon, however the functional significance of this variant is currently unknown. This variant has a maximum subpopulation frequency of 0.012% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/). This variant has not been reported in individuals with SRP72-associated bone marrow failure. In summary, the evidence currently available is insufficient to determine the clinical significance of this variant. It has therefore been classified as of uncertain significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at